ID

33544

Descripción

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Palabras clave

Versiones (2)
  1. 12/12/18 12/12/18 -
  2. 6/6/19 6/6/19 -
Titular de derechos de autor

GSK group of companies

Subido en

12 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)

Inglés

Visit 3: Study Continuation Check

1 formularios  
Administrative data
Descripción

Administrative data

Protocol Number
Descripción

Protocol Number

Tipo de datos

integer

Subject Number
Descripción

Subject Number

Tipo de datos

integer

Date of Visit
Descripción

Date of Visit

Tipo de datos

date

Period
Descripción

Period

Tipo de datos

text

Check for Study Continuation
Descripción

Check for Study Continuation

Did the subject return for visit 3?
Descripción

Did the subject return for visit 3?

Tipo de datos

boolean

If No, please tick one most appropriate reason
Descripción

If No, please tick one most appropriate reason

Tipo de datos

text

If Serious adverse event, please specify the SAE number
Descripción

If Serious adverse event, please specify the SAE number

Tipo de datos

integer

If Other, please specify
Descripción

If Other, please specify

Tipo de datos

text

Please tick who took the decision
Descripción

Please tick who took the decision

Tipo de datos

text

Volver a la parte superior de la página

Similar models

Visit 3: Study Continuation Check

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Protocol Number
Item
Protocol Number
integer
Subject Number
Item
Subject Number
integer
Date of Visit
Item
Date of Visit
date
Item
Period
text
Period
Code List
Period
CL Item
45 months post dose 1 in Malaria-026 (12 months after visit 2) (1)
Item Group
Check for Study Continuation
Did the subject return for visit 3?
Item
Did the subject return for visit 3?
boolean
Item
If No, please tick one most appropriate reason
text
If No, please tick one most appropriate reason
Code List
If No, please tick one most appropriate reason
CL Item
Serious adverse event (1)
CL Item
Other (2)
If Serious adverse event, please specify the SAE number
Item
If Serious adverse event, please specify the SAE number
integer
If Other, please specify
Item
If Other, please specify
text
Item
Please tick who took the decision
text
Please tick who took the decision
Code List
Please tick who took the decision
CL Item
Investigator (I)
CL Item
Parents/Guardians (P)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial